HealthEquity officer proposes $99.8K share sale

The transaction is described as issuer-mandated to fund tax withholding through a sell-to-cover arrangement, not as a discretionary trade.

Rhea-AI Filing Summary

HealthEquity, Inc. (HQY) lists a proposed sale by officer and director Stephen Neeleman of 1,095 common shares, with an aggregate market value of $99,815.07 and an approximate sale date of October 6, 2026, through Morgan Stanley Smith Barney. The securities list includes restricted-stock vesting entries of 410, 300 and 385 shares. The sale is described as issuer-mandated to fund a tax-withholding obligation through a “sell to cover” transaction, not as a discretionary trade. Neeleman also reported selling 1,103 shares for an aggregate market value of $104,876.64 on July 8, 2026.

Key Figures

Proposed shares for sale: 1,095 common shares Aggregate market value: $99,815.07 Restricted-stock vesting: 410 shares +4 more

7 metrics

Proposed shares for sale 1,095 common shares Approximate sale date October 6, 2026

Aggregate market value $99,815.07 Proposed sale

Restricted-stock vesting 410 shares March 29, 2023

Restricted-stock vesting 300 shares March 27, 2024

Restricted-stock vesting 385 shares April 2, 2025

Shares sold in prior three months 1,103 common shares July 8, 2026

Aggregate market value $104,876.64 Sale on July 8, 2026

Key Terms

Rule 144, sell to cover, restricted stock vesting, equity incentive plan, +1 more

5 terms

Rule 144 regulatory

"paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

sell to cover financial

"funded by a "sell to cover" transaction"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

restricted stock vesting financial

"Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

equity incentive plan financial

"under its equity incentive plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

tax withholding obligation financial

"satisfaction of a tax withholding obligation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HQY shares did Stephen Neeleman report for sale?

Stephen Neeleman’s proposed sale covers 1,095 common shares, with an aggregate market value of $99,815.07 and an approximate sale date of October 6, 2026. Morgan Stanley Smith Barney is listed as the broker.

Why was Stephen Neeleman’s HQY sale made?

The sale is described as mandated by the issuer’s election under its equity incentive plan to fund a tax-withholding obligation through a “sell to cover” transaction; it is not described as a discretionary trade.

How many HQY shares had Stephen Neeleman sold in the prior three months?

Neeleman reported selling 1,103 common shares on July 8, 2026, with an aggregate market value of $104,876.64.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/08/2026 - 06:06 PM Accepted by SEC EDGAR 10/08/2026 - 06:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001614838
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHEQUITY, INC.
SEC File Number	001-36568
Address of Issuer	15 WEST SCENIC POINTE DRIVE SUITE 100 DRAPER UTAH 84020
Phone	801.727.1000
Name of Person for Whose Account the Securities are To Be Sold	Stephen Neeleman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney 2000 Westchester Ave Purchase NY 10577-2530	1095	99815.07	82715296	10/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/29/2023	Restricted Stock Vesting	ISSUER			410	10/06/2026	Compensation
Common Stock	03/27/2024	Restricted Stock Vesting	ISSUER			300	10/06/2026	Compensation
Common Stock	04/02/2025	Restricted Stock Vesting	ISSUER			385	10/06/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Neeleman C/O HealthEquity, Inc. 15 W.Scenic Pointe Dr. Ste, 100 Draper UT 84020	Common Stock	07/08/2026	1103	104876.64

144: Remarks and Signature

Remarks	This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Date of Notice	10/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Stephen Neeleman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)